Income Taxes	9 Months Ended
Income Taxes	Sep. 30, 2021
Income Tax Disclosure [Abstract]
Income Taxes	INCOME TAXES The Company evaluates the balance of deferred tax assets that will be realized based on the premise that the Company is more likely than not to realize deferred tax benefits through the generation of future taxable income. Management makes assumptions, judgments, and estimates to determine the deferred tax assets and liabilities. The Company evaluates provisions and deferred tax assets quarterly to determine if adjustments to our valuation allowance are required based on the consideration of all available evidence. The Company’s Consolidated Balance Sheets include net deferred tax assets of $460,000 for the Canadian and $469,000 for Mexican tax jurisdictions and a net deferred tax liability of $288,000 for the U.S. tax jurisdiction at September 30, 2021. The deferred tax asset is classified in other non-current assets and deferred tax liabilities are in other non-current liabilities. During the nine months ended September 30, 2021, the Company increased its valuation allowance from $1,193,000 at December 31, 2020 to $2,259,000 at September 30, 2021. The valuation allowance is against the interest limitation carryforward, U.S. state and local net loss carryforward and a portion of the U.S. federal net loss carryforward, due to cumulative losses in the United States over the last three years and uncertainty related to the Company's ability to realize the deferred assets. The Company believes that the deferred tax assets associated with the Canadian and Mexican tax jurisdictions are more-likely-than-not to be realizable based on estimates of future taxable income. Income tax expense for the nine months ended September 30, 2021 is estimated to be $3,290,000, approximately 43.8% of income before income taxes, and includes tax expense in Canadian and Mexican tax jurisdictions and a valuation allowance of $1,066,000 against U.S. tax jurisdiction deferred tax assets, offset by a tax benefit in U.S. tax jurisdictions. Income tax benefit for the nine months ended September 30, 2020 was estimated to be $4,933,000, approximately 120.3% of income before income taxes. On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (the "CARES Act") was enacted in response to the COVID-19 pandemic, and among other things, provides tax relief to businesses. Tax provisions of the CARES Act include the deferral of certain payroll taxes, relief for retaining employees, and other provisions, including allowing net operating losses to be carried back five years versus an indefinite carryforward. An income tax benefit of $5,638,000 was realized in the first quarter of 2020. The income tax benefit consists of the reversal of the full valuation allowance against net deferred tax assets in the United States for approximately $3,267,000. The income tax benefit also consists of a rate benefit of $2,371,000 based on the losses being carried back to years where the Company paid tax at 34% compared to the valuation of the losses being recorded at the 21% current U.S. statutory tax rate. The Company files income tax returns in the U.S., Mexico, Canada and various state jurisdictions. The Company is not subject to U.S. federal and state income tax examinations by tax authorities for years prior to 2017, not subject to Mexican income tax examinations by Mexican authorities for years prior to 2015 and not subject to Canadian tax examinations by Canadian authorities for years prior to 2018.

The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.